Walker V E, Gorelick N J, Andrews J L, Craft T R, deBoer J G, Glickman B W, Skopek T R
Department of Pathology, University of North Carolina, Chapel Hill 27599, USA.
Cancer Res. 1996 Oct 15;56(20):4654-61.
The development of mouse models with the endogenous hypoxanthine-guanine phosphoribosyl transferase (hprt) gene and lacI transgene as mutational targets provides an excellent opportunity to compare the mutant frequency (Mf) and types of mutations induced in vivo in different sequence contexts. To this end, a study was conducted to determine the Mfs and spectrum of mutations induced at these loci in splenic T cells from male B6C3F1 Big Blue mice (6 weeks old) exposed to N-ethyl-N-nitrosourea (ENU). Six weeks after i.p. injection of 40 mg ENU/kg, T cells were isolated from control (n = 7) and treated (n = 8) mice for the culture of hprt mutants and for the extraction of DNA and recovery of lacI mutants. Mutations in hprt exon 3 and in lacI were quantified and analyzed using published procedures (S. W. Kohler et al., Proc. Natl. Acad. Sci. USA, 88: 7958-7962, 1991; T. R. Skopek et al., Proc. Natl. Acad. Sci. USA, 89: 7866-7870, 1992). In treated mice, the Mfs (average +/- SE) in hprt (6.0 +/- 0.2 x 10(-5)) and lacI (11.4 +/- 1.8 x 10(-5)) were approximately 16.2-fold (P = 0.006) and 3.4-fold (P = 0.009), respectively, above controls. However, the average induced Mfs (i.e., induced Mf = treatment Mf - background Mf) in hprt and lacI were similar, with the respective increases in Mf being 5.6 +/- 0.2 x 10(-5) and 8.0 +/- 2.3 x 10(-5) over background. Eleven of the 107 hprt mutants from treated Big Blue mice had mutations in exon 3, with 73% being substitutions at AxT bp. These data are similar to those observed in ENU-exposed nontransgenic B6C3F1 mice, in which 62 of 69 exon 3 mutations were substitutions at AxT bp (T. R. Skopek et al., Proc. Natl. Acad. Sci. USA, 89: 7866-7870, 1992). For comparison, the sequences of the lacI genes in two to five mutants from each mouse were determined, and a total of 75 mutations (70 different mutations) was detected. In exposed mice, 55% (24 of 44) of the mutations in lacI were substitutions at AxT bp. In controls, substitutions at AT bp comprised only 20% of the recovered mutations in either hprt exon 3 (1 of 5) or lacI (5 of 26). These data indicate that the lacI mutation assay is less sensitive than the hprt assay for detecting increases in Mf induced by ENU exposure of mice as indicated by the lower relative increase in Mf in the lacI gene, but, given a 6-week expression time, the types of mutations induced by ENU in the transgene reflect those observed in the native transcribed gene.
以内源性次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶(hprt)基因和lacI转基因作为突变靶点的小鼠模型的开发,为比较不同序列背景下体内诱导的突变频率(Mf)和突变类型提供了绝佳机会。为此,进行了一项研究,以确定暴露于N - 乙基 - N - 亚硝基脲(ENU)的雄性B6C3F1大蓝小鼠(6周龄)脾脏T细胞中这些位点诱导的Mf和突变谱。腹腔注射40 mg ENU/kg六周后,从对照(n = 7)和处理过的(n = 8)小鼠中分离T细胞,用于培养hprt突变体以及提取DNA和回收lacI突变体。使用已发表的程序(S. W. Kohler等人,《美国国家科学院院刊》,88: 7958 - 7962,1991;T. R. Skopek等人,《美国国家科学院院刊》,89: 7866 - 7870,1992)对hprt外显子3和lacI中的突变进行定量和分析。在处理过的小鼠中,hprt(6.0 +/- 0.2 x 10(-5))和lacI(11.4 +/- 1.8 x 10(-5))的Mf分别比对照高约16.2倍(P = 0.006)和3.4倍(P = 0.009)。然而,hprt和lacI的平均诱导Mf(即,诱导Mf = 处理组Mf - 背景Mf)相似,Mf相对于背景的各自增加量分别为5.6 +/- 0.2 x 10(-5)和8.0 +/- 2.3 x 10(-5)。来自处理过的大蓝小鼠的107个hprt突变体中有11个在外显子3中发生突变,其中73%是A/T碱基对处的替换。这些数据与在暴露于ENU的非转基因B6C3F1小鼠中观察到的数据相似,在这些小鼠中,69个外显子3突变中有62个是A/T碱基对处的替换(T. R. Skopek等人,《美国国家科学院院刊》,89: 7866 - 7870,1992)。为了进行比较,测定了每只小鼠2至5个突变体中lacI基因的序列,共检测到75个突变(70个不同的突变)。在暴露的小鼠中,lacI中55%(44个中的24个)的突变是A/T碱基对处的替换。在对照中,A/T碱基对处的替换仅占hprt外显子3(5个中的1个)或lacI(26个中的5个)中回收突变的20%。这些数据表明,就lacI基因中Mf的相对增加较低而言,lacI突变检测法在检测ENU暴露小鼠诱导的Mf增加方面不如hprt检测法敏感,但是,在6周的表达时间下,ENU在转基因中诱导的突变类型反映了在天然转录基因中观察到的那些突变类型。